Epidemiologic study of cystic fibrosis

Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada

Wayne J. Morgan, Steven M. Butler, Charles A. Johnson, Andrew Colin, Stacey C. FitzSimmons, David E. Geller, Michael W. Konstan, Michael J. Light, Harvey R. Rabin, Warren E. Regelmann, Daniel V. Schidlow, Dennis C. Stokes, Mary Ellen B Wohl, Haley Kaplowitz, Matthew M. Wyatt, Scott Stryker

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

Cystic fibrosis (CF) is a complex illness characterized by chronic lung infection leading to deterioration in function and respiratory failure in over 85% of patients. An understanding of the risk factors for that progression and the interaction of these factors with current therapeutic strategies should materially improve the prevention of this progressive lung disease. The Epidemiologic Study of Cystic Fibrosis (ESCF) was therefore designed as a multicenter, longitudinal, observational study to prospectively collect detailed clinical, therapeutic, microbiologic, and lung function data from a large number of CF treatment sites in the U.S. and Canada. The ESCF also serves an important role as a phase-IV study of dornase alfa. To be eligible for enrollment, subjects must have the diagnosis of CF and receive the majority of their care at an ESCF site. In this paper, the authors present the ESCF study design in detail. Further, enrollment data collected at 194 study sites in 18,411 subjects en rolled from December 1, 1993 to December 31, 1995 are presented in summary form. This comprehensive study is unique in the detail of clinical data collected regarding patient monitoring and therapeutic practices in CF care. Two companion articles present data regarding practice patterns in cystic fibrosis care, including data on resource utilization and prescribing practices.

Original languageEnglish
Pages (from-to)231-241
Number of pages11
JournalPediatric Pulmonology
Volume28
Issue number4
DOIs
StatePublished - Oct 1 1999
Externally publishedYes

Fingerprint

Cystic Fibrosis
Multicenter Studies
Canada
Observational Studies
Epidemiologic Studies
Lung
Physiologic Monitoring
Therapeutics
Respiratory Insufficiency
Lung Diseases
Longitudinal Studies
Chronic Disease
Infection

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Epidemiologic study of cystic fibrosis : Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. / Morgan, Wayne J.; Butler, Steven M.; Johnson, Charles A.; Colin, Andrew; FitzSimmons, Stacey C.; Geller, David E.; Konstan, Michael W.; Light, Michael J.; Rabin, Harvey R.; Regelmann, Warren E.; Schidlow, Daniel V.; Stokes, Dennis C.; Wohl, Mary Ellen B; Kaplowitz, Haley; Wyatt, Matthew M.; Stryker, Scott.

In: Pediatric Pulmonology, Vol. 28, No. 4, 01.10.1999, p. 231-241.

Research output: Contribution to journalArticle

Morgan, WJ, Butler, SM, Johnson, CA, Colin, A, FitzSimmons, SC, Geller, DE, Konstan, MW, Light, MJ, Rabin, HR, Regelmann, WE, Schidlow, DV, Stokes, DC, Wohl, MEB, Kaplowitz, H, Wyatt, MM & Stryker, S 1999, 'Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada', Pediatric Pulmonology, vol. 28, no. 4, pp. 231-241. https://doi.org/10.1002/(SICI)1099-0496(199910)28:4<231::AID-PPUL1>3.0.CO;2-2
Morgan, Wayne J. ; Butler, Steven M. ; Johnson, Charles A. ; Colin, Andrew ; FitzSimmons, Stacey C. ; Geller, David E. ; Konstan, Michael W. ; Light, Michael J. ; Rabin, Harvey R. ; Regelmann, Warren E. ; Schidlow, Daniel V. ; Stokes, Dennis C. ; Wohl, Mary Ellen B ; Kaplowitz, Haley ; Wyatt, Matthew M. ; Stryker, Scott. / Epidemiologic study of cystic fibrosis : Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. In: Pediatric Pulmonology. 1999 ; Vol. 28, No. 4. pp. 231-241.
@article{f9cd97ce23a94098a33cd5091fc4ec9a,
title = "Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada",
abstract = "Cystic fibrosis (CF) is a complex illness characterized by chronic lung infection leading to deterioration in function and respiratory failure in over 85{\%} of patients. An understanding of the risk factors for that progression and the interaction of these factors with current therapeutic strategies should materially improve the prevention of this progressive lung disease. The Epidemiologic Study of Cystic Fibrosis (ESCF) was therefore designed as a multicenter, longitudinal, observational study to prospectively collect detailed clinical, therapeutic, microbiologic, and lung function data from a large number of CF treatment sites in the U.S. and Canada. The ESCF also serves an important role as a phase-IV study of dornase alfa. To be eligible for enrollment, subjects must have the diagnosis of CF and receive the majority of their care at an ESCF site. In this paper, the authors present the ESCF study design in detail. Further, enrollment data collected at 194 study sites in 18,411 subjects en rolled from December 1, 1993 to December 31, 1995 are presented in summary form. This comprehensive study is unique in the detail of clinical data collected regarding patient monitoring and therapeutic practices in CF care. Two companion articles present data regarding practice patterns in cystic fibrosis care, including data on resource utilization and prescribing practices.",
author = "Morgan, {Wayne J.} and Butler, {Steven M.} and Johnson, {Charles A.} and Andrew Colin and FitzSimmons, {Stacey C.} and Geller, {David E.} and Konstan, {Michael W.} and Light, {Michael J.} and Rabin, {Harvey R.} and Regelmann, {Warren E.} and Schidlow, {Daniel V.} and Stokes, {Dennis C.} and Wohl, {Mary Ellen B} and Haley Kaplowitz and Wyatt, {Matthew M.} and Scott Stryker",
year = "1999",
month = "10",
day = "1",
doi = "10.1002/(SICI)1099-0496(199910)28:4<231::AID-PPUL1>3.0.CO;2-2",
language = "English",
volume = "28",
pages = "231--241",
journal = "Pediatric Pulmonology",
issn = "8755-6863",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Epidemiologic study of cystic fibrosis

T2 - Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada

AU - Morgan, Wayne J.

AU - Butler, Steven M.

AU - Johnson, Charles A.

AU - Colin, Andrew

AU - FitzSimmons, Stacey C.

AU - Geller, David E.

AU - Konstan, Michael W.

AU - Light, Michael J.

AU - Rabin, Harvey R.

AU - Regelmann, Warren E.

AU - Schidlow, Daniel V.

AU - Stokes, Dennis C.

AU - Wohl, Mary Ellen B

AU - Kaplowitz, Haley

AU - Wyatt, Matthew M.

AU - Stryker, Scott

PY - 1999/10/1

Y1 - 1999/10/1

N2 - Cystic fibrosis (CF) is a complex illness characterized by chronic lung infection leading to deterioration in function and respiratory failure in over 85% of patients. An understanding of the risk factors for that progression and the interaction of these factors with current therapeutic strategies should materially improve the prevention of this progressive lung disease. The Epidemiologic Study of Cystic Fibrosis (ESCF) was therefore designed as a multicenter, longitudinal, observational study to prospectively collect detailed clinical, therapeutic, microbiologic, and lung function data from a large number of CF treatment sites in the U.S. and Canada. The ESCF also serves an important role as a phase-IV study of dornase alfa. To be eligible for enrollment, subjects must have the diagnosis of CF and receive the majority of their care at an ESCF site. In this paper, the authors present the ESCF study design in detail. Further, enrollment data collected at 194 study sites in 18,411 subjects en rolled from December 1, 1993 to December 31, 1995 are presented in summary form. This comprehensive study is unique in the detail of clinical data collected regarding patient monitoring and therapeutic practices in CF care. Two companion articles present data regarding practice patterns in cystic fibrosis care, including data on resource utilization and prescribing practices.

AB - Cystic fibrosis (CF) is a complex illness characterized by chronic lung infection leading to deterioration in function and respiratory failure in over 85% of patients. An understanding of the risk factors for that progression and the interaction of these factors with current therapeutic strategies should materially improve the prevention of this progressive lung disease. The Epidemiologic Study of Cystic Fibrosis (ESCF) was therefore designed as a multicenter, longitudinal, observational study to prospectively collect detailed clinical, therapeutic, microbiologic, and lung function data from a large number of CF treatment sites in the U.S. and Canada. The ESCF also serves an important role as a phase-IV study of dornase alfa. To be eligible for enrollment, subjects must have the diagnosis of CF and receive the majority of their care at an ESCF site. In this paper, the authors present the ESCF study design in detail. Further, enrollment data collected at 194 study sites in 18,411 subjects en rolled from December 1, 1993 to December 31, 1995 are presented in summary form. This comprehensive study is unique in the detail of clinical data collected regarding patient monitoring and therapeutic practices in CF care. Two companion articles present data regarding practice patterns in cystic fibrosis care, including data on resource utilization and prescribing practices.

UR - http://www.scopus.com/inward/record.url?scp=13044254788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13044254788&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1099-0496(199910)28:4<231::AID-PPUL1>3.0.CO;2-2

DO - 10.1002/(SICI)1099-0496(199910)28:4<231::AID-PPUL1>3.0.CO;2-2

M3 - Article

VL - 28

SP - 231

EP - 241

JO - Pediatric Pulmonology

JF - Pediatric Pulmonology

SN - 8755-6863

IS - 4

ER -